Change search
ReferencesLink to record
Permanent link

Direct link
SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Pathology.
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Pathology.
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Pathology.
Umeå University, Faculty of Medicine, Department of Surgical and Perioperative Sciences, Surgery.
Show others and affiliations
2016 (English)In: BMC Cancer, ISSN 1471-2407, E-ISSN 1471-2407, Vol. 16, 471Article in journal (Refereed) PublishedText
Abstract [en]

Background: To improve current treatment strategies for patients with aggressive colorectal cancer (CRC), the molecular understanding of subgroups of CRC with poor prognosis is of vast importance. SOX2 positive tumors have been associated with a poor patient outcome, but the functional role of SOX2 in CRC patient prognosis is still unclear. Methods: An in vitro cell culture model expressing SOX2 was used to investigate the functional role of SOX2 in CRC. In vitro findings were verified using RNA from fresh frozen tumor tissue or immunohistochemistry on formalin fixed paraffin embedded (FFPE) tumor tissue from a cohort of 445 CRC patients. Results: Using our in vitro model, we found that SOX2 expressing cells displayed several characteristics of cancer stem cells; such as a decreased proliferative rate, a spheroid growth pattern, and increased expression of stem cell markers CD24 and CD44. Cells expressing SOX2 also showed down-regulated expression of the intestinal epithelial marker CDX2. We next evaluated CDX2 expression in our patient cohort. CDX2 down-regulation was more often found in right sided tumors of high grade and high stage. Furthermore, a decreased expression of CDX2 was closely linked to MSI, CIMP-high as well as BRAF mutated tumors. A decreased expression of CDX2 was also, in a stepwise manner, strongly correlated to a poor patient prognosis. When looking at SOX2 expression in relation to CDX2, we found that SOX2 expressing tumors more often displayed a down-regulated expression of CDX2. In addition, SOX2 expressing tumors with a down-regulated CDX2 expression had a worse patient prognosis compared to those with retained CDX2 expression. Conclusions: Our results indicate that SOX2 expression induces a cellular stem cell state in human CRC with a decreased expression of CDX2. Furthermore, a down-regulated expression of CDX2 results in a poor patient prognosis in CRC and at least part of the prognostic importance of SOX2 is mediated through CDX2 down-regulation.

Place, publisher, year, edition, pages
2016. Vol. 16, 471
Keyword [en]
SOX2, CDX2, Colorectal cancer, Prognosis, Cancer stem cell
National Category
Cell and Molecular Biology Cancer and Oncology
Identifiers
URN: urn:nbn:se:umu:diva-124507DOI: 10.1186/s12885-016-2509-5ISI: 000380091600001PubMedID: 27411517OAI: oai:DiVA.org:umu-124507DiVA: diva2:953888
Available from: 2016-08-19 Created: 2016-08-15 Last updated: 2016-08-19Bibliographically approved

Open Access in DiVA

fulltext(5783 kB)16 downloads
File information
File name FULLTEXT01.pdfFile size 5783 kBChecksum SHA-512
9ca6628a98089ff347ca58bca8b73cb89b2091509337a4f7a912fd51e8047fba54477c6c5852db4ff6f3494f19fc299f503f020c895709bb428d609073c7997e
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Lundberg, Ida V.Edin, SofiaEklöf, VincyÖberg, ÅkePalmqvist, RichardWikberg, Maria L.
By organisation
PathologySurgery
In the same journal
BMC Cancer
Cell and Molecular BiologyCancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 16 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 37 hits
ReferencesLink to record
Permanent link

Direct link